Triple M Syndrome After Immune Checkpoint Inhibition: A Rare and Life-Threatening Triad of Myocarditis, Myositis, and Myasthenia Gravis.

Saved in:
Bibliographic Details
Title: Triple M Syndrome After Immune Checkpoint Inhibition: A Rare and Life-Threatening Triad of Myocarditis, Myositis, and Myasthenia Gravis.
Authors: Albastaki E; Acute Medicine, The Dudley Group NHS Foundation Trust, Dudley, GBR., Rishu R; General Internal Medicine, The Dudley Group NHS Foundation Trust, Dudley, GBR., Tun Y; Acute Medicine, The Dudley Group NHS Foundation Trust, Dudley, GBR., Abdullah A; Cardiology, South Warwickshire University NHS Foundation Trust, Warwick, GBR., Bhattacharjee S; Neurology, The Dudley Group NHS Foundation Trust, Dudley, GBR.
Source: Cureus [Cureus] 2025 Nov 10; Vol. 17 (11), pp. e96514. Date of Electronic Publication: 2025 Nov 10 (Print Publication: 2025).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2168-8184
DOI:10.7759/cureus.96514